News
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...
Binge eating disorder is strongly associated with weight gain and obesity, though not all individuals with obesity have BED.
Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway found a 45% lower risk in ...
1dOpinion
The Star on MSNDR NELLY: Kenya’s quiet shift in diabetes and obesity treatmentKenya’s healthcare system is witnessing a quiet transformation with the introduction of newer therapies for managing Type 2 ...
Eli Lilly outpaces Novo in the GLP-1 market with Tirzepatide and emerging blockbusters, signaling future growth. Read more on ...
1h
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side effects.
A WOMAN who lost a staggering five stone thanks to weight-loss jabs has hit back at trolls who brand her an “Ozempic cheat”.
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...
It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results